Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine dosing to reduce rebound pain after peripheral nerve block
jRCT1031240124Recruiting
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in upper extremity fracture (2 arms). Primary endpoint: Incidence of rebound pain. Started Apr 2024; status: recruiting.
02
Drugs
ketamine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on jRCT1031240124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240124.